Screening for Adverse Drug Events: a Randomized Trial of Automated Calls Coupled with Phone-Based Pharmacist Counseling

Schiff, Gordon D.; Klinger, Elissa V.; Salazar, Alejandra; Medoff, Jeffrey; Amato, Mary G.; Orav, E. John; Shaykevich, Shimon; Seoane, Enrique; Walsh, Lake; Fuller, Theresa E.; Dykes, Patricia C.; Bates, David W.; Haas, Jennifer S.

doi:10.1007/s11606-018-4672-7

Cited by 15 publications

(18 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Therefore, the community pharmacists can assess possible adverse events and inform prescribing doctors. 22,23 Interestingly, tracing reports submitted by the pharmacists who experienced face-to-face communication with the prescribing doctors did not signi cantly in uence to the deprescribing success rate, although a previous study mentioned that face-to-face communication with doctors is important for deprescribing. 24 This difference may have occurred because the past study did not perform a quantitative evaluation, whereas the present study did.…”

Section: Discussionmentioning

confidence: 92%

Searching for Success Factors in Deprescribing Proposals from Community Pharmacists

Osada¹

2021

Preprint

View full text Add to dashboard Cite

BackgroundPolypharmacy is one of the most critical issues worldwide, especially in elderly people. In Japan, fees to support deprescription were established in 2018 which are calculated as the community pharmacists propose deprescribing in patients prescribed 6 or more medications regularly by submitting documents to the prescribing doctor, who may withdraw 2 or more medications. However, these are hardly calculated though many deprescribing proposals submitted.ObjectiveThe objective in this study, success factors in deprescribing proposals from the community pharmacists to prescribing doctors were searched for.MethodsTracing reports submitted from Aug 2017 to Mar 2020 were investigated retrospectively and factors that influenced the success of deprescribing were searched for.ResultsOne hundred and twenty-three tracing reports (67 reports of successful deprescribing and 56 reports of failure, success rate was 54.5%) were submitted to the prescribing doctors. Deprescribing proposals with existing unused medications or an assessment of possible adverse events significantly increased the deprescribing success rate. Whether the pharmacist experienced face-to-face communication with the prescribing doctors was not significant.ConclusionTracing reports with deprescribing proposals submitted by the community pharmacists may resolve polypharmacy. Mentioning unused medications or possible adverse events could increase the deprescribing success rate.

show abstract

Section: Discussionmentioning

confidence: 92%

Searching for Success Factors in Deprescribing Proposals from Community Pharmacists

Osada¹

2021

Preprint

View full text Add to dashboard Cite

show abstract

“…Therefore, community pharmacists are in a position to assess potential inappropriate medications, overlapping same-effect medications, or possible adverse events and inform prescribing doctors. [28], [29] Interestingly, tracing reports submitted by pharmacists who had experienced face-to-face communication with the prescribing doctors did not signi cantly in uence the deprescribing success rate, although a previous study mentioned that face-to-face communication with doctors is important for deprescribing. [30] This difference may have occurred because the past study did not perform a quantitative evaluation, whereas this study did.…”

Section: Discussionmentioning

confidence: 99%

Examining Success Factors in Deprescribing Proposals from Community Pharmacists

Osada¹

2021

Preprint

View full text Add to dashboard Cite

Background: Polypharmacy is a critical issue that affects elderly people in particular. In Japan, fees to support deprescription are calculated bycommunity pharmacists who propose deprescribing 2 or more medications for patients prescribed 6 or more. However, the fees are rarely calculated.The objective of this study is toexamine success factors in deprescribing proposals submitted bycommunity pharmacists to prescribing doctors.Methods: Tracing reports submitted from Aug 2017 to Mar 2020 were investigated retrospectively to uncover factors that influenced the success of deprescribing using statisticalanalyses.Results:One hundred and twenty-three unique tracing reports were submitted to the prescribing doctors. Of these, 67 reports were successful in deprescribing and 56 failed; the success rate was 54.5%. Deprescribing proposals with existingunused medications significantly increased the deprescribing success rate. Possible adverse events, potentially inappropriate medications, and overlapping medications with the same effecttended to increase the success rate, but not significantly. Whether the pharmacist experienced face-to-face communication with the prescribing doctors did not significantly influence the outcome.Conclusions:Tracing reports with deprescribing proposals submitted by community pharmacists may help resolve problems arising frompolypharmacy. Mentioning unused medications could increase the deprescribing success rate.Trial registration: This study did not registered due to purely observational study.

show abstract

“…As described above, academic studies of adverse drug events (ADEs) consistently reveal very high rates of harm. That same scientific literature shows that, without systematic surveillance and monitoring, most ADEs go undetected and unreported 54‐56 . Surveillance and monitoring describe a wide range of possible interventions.…”

Section: Introductionmentioning

confidence: 94%

“…That same scientific literature shows that, without systematic surveillance and monitoring, most ADEs go undetected and unreported. [54][55][56] Surveillance and monitoring describe a wide range of possible interventions. It can be as straightforward as requiring monitoring of pulse oxygenation or capnography when using moderate sedation, which would have saved Ms. Murphey's life after the mistaken vecuronium dose.…”

Section: Draw Attention To Production Pressures and Their Effect On T...mentioning

confidence: 99%

RaDonda Vaught, medication safety, and the profession of pharmacy: Steps to improve safety and ensure justice

Lambert

Schiff

2022

J Am Coll Clin Pharm

Self Cite

View full text Add to dashboard Cite

The prosecution and ultimate conviction of nurse RaDonda Vaught is both a warning and a call to action for pharmacists and the profession of pharmacy. This essay outlines nine steps that should be taken to maximize patient safety and minimize the risk of criminal prosecution for harm that results from human error. These include advocating for safe practices that reduce the risk of wrong drug errors; using pharmacy professional organizations to educate prosecutors about just culture and system safety; strengthening the focus on at-risk behaviors and the normalization of deviance; training a cohort of clinicians to serve as expert witnesses for the defense; embracing communication and resolution programs as responses to unexpected harm; encouraging and supporting conservative medication use to minimize exposure to medication risks; drawing attention to production pressures and their impact on patient safety and clinician burnout; promoting proactive surveillance for adverse drug effects; and standing in solidarity with other health professions, especially nursing.

show abstract

Screening for Adverse Drug Events: a Randomized Trial of Automated Calls Coupled with Phone-Based Pharmacist Counseling

Cited by 15 publications

References 24 publications

Searching for Success Factors in Deprescribing Proposals from Community Pharmacists

Searching for Success Factors in Deprescribing Proposals from Community Pharmacists

Examining Success Factors in Deprescribing Proposals from Community Pharmacists

RaDonda Vaught, medication safety, and the profession of pharmacy: Steps to improve safety and ensure justice

Contact Info

Product

Resources

About